Trial Profile
Postmarketing study assessing safety of fixed dose combination of Ledipasvir/Sofosbuvir in Chronic Hepatitis C Virus Infection Therapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2016
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- 05 Nov 2016 New trial record